Covered recipient · General Payments record
MARIELA COGORNO
General Payments · PY2018–2024
$2,725.51
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $560.75 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $216.87 | 8 |
| REVANCE THERAPEUTICS, INC. | $173.54 | 3 |
| MERZ NORTH AMERICA, INC. | $105.54 | 3 |
| Galderma Laboratories, L.P. | $64.80 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.25 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484779 | CMS |
| ABBVIE INC. | $17.61 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484781 | CMS |
| ABBVIE INC. | $2.51 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484783 | CMS |
| ABBVIE INC. | $117.65 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484785 | CMS |
| ABBVIE INC. | $4.57 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484787 | CMS |
| ABBVIE INC. | $21.15 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484789 | CMS |
| ABBVIE INC. | $27.50 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484791 | CMS |
| ABBVIE INC. | $11.63 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103484793 | CMS |
| Galderma Laboratories, L.P. | $21.58 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145291328 | CMS |
| Galderma Laboratories, L.P. | $24.56 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145291330 | CMS |
| Galderma Laboratories, L.P. | $18.66 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145291332 | CMS |
| MERZ NORTH AMERICA, INC. | $35.71 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146372826 | CMS |
| MERZ NORTH AMERICA, INC. | $32.88 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146372828 | CMS |
| MERZ NORTH AMERICA, INC. | $36.95 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146372830 | CMS |
| REVANCE THERAPEUTICS, INC. | $110.21 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147914979 | CMS |
| REVANCE THERAPEUTICS, INC. | $27.95 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147914981 | CMS |
| REVANCE THERAPEUTICS, INC. | $35.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147914983 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.